SCHEMBL9813545

SCHEMBL9813545

CN1C(=O)CS/C1=C\C(=O)Nc1ccccc1Cl

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.71
▸ TDP1 Q9NUW8 1/20 0.71
▸ PSMD14 O00487 1/20 0.52
▸ MMP1 P03956 4/20 0.43
▸ MMP2 P08253 4/20 0.43
▸ MMP9 P14780 4/20 0.43
▸ EGFR P00533 1/20 0.43
▸ TAS1R3 Q7RTX0 1/20 0.40
▸ TAS1R1 Q7RTX1 1/20 0.40
▸ TAS1R2 Q8TE23 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ GAA P10253 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ HPGD P15428 3/20 0.39
▸ TSHR P16473 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ APOBEC3A P31941 1/20 0.39
▸ CTDSP1 Q9GZU7 1/20 0.39
▸ APOBEC3G Q9HC16 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9813546 1.00 ALDH1A1 (0.71) ALDH1A1TDP1PSMD14MMP1MMP2
SCHEMBL9813551 0.86 ALDH1A1 (0.59) ALDH1A1TDP1PSMD14MAPTGAA
SCHEMBL9813552 0.86 ALDH1A1 (0.59) ALDH1A1TDP1PSMD14MAPTGAA
Ralitoline SCHEMBL635346 0.82 PSMD14 (0.55) ALDH1A1TDP1PSMD14EGFRGAA
Ralitoline SCHEMBL9813595 0.82 PSMD14 (0.55) ALDH1A1TDP1PSMD14EGFRGAA
SCHEMBL9813589 0.82 ALDH1A1 (0.66) ALDH1A1TDP1PSMD14MMP1MMP2
SCHEMBL9813586 0.82 ALDH1A1 (0.66) ALDH1A1TDP1PSMD14MMP1MMP2
SCHEMBL9813652 0.81 ALDH1A1 (0.66) ALDH1A1TDP1PSMD14MAPTGAA
SCHEMBL9813604 0.80 ALDH1A1 (0.57) ALDH1A1TDP1PSMD14MMP1MMP2
SCHEMBL9813602 0.80 ALDH1A1 (0.57) ALDH1A1TDP1PSMD14MMP1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0124911-B1 4-OXO-THIAZOLIDIN-2-YLIDEN-ACETAMIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND MEDICAMENTS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM ILLNESSES CONTAINING THEM GÖDECKE AKTIENGESELLSCHAFT (DE) 1991-07-31 — — EP disclosed
US-4563471-A CENTRAL NERVOUS SYSTEM DISORDERS WARNER-LAMBERT COMPANY (US) 1986-01-07 — — US disclosed
EP-0124911-A2 4-Oxo-thiazolidin-2-yliden-acetamide derivatives, process for their preparation, and medicaments for the treatment of central nervous system illnesses containing them GÖDECKE AKTIENGESELLSCHAFT (DE) 1984-11-14 — — EP disclosed
Send feedback